Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors.
Front Endocrinol (Lausanne). 2023 Feb 15;14:951099. doi: 10.3389/fendo.2023.951099. eCollection 2023.
Front Endocrinol (Lausanne). 2023.
PMID: 36875461
Free PMC article.
Review.
Sodium-Glucose Cotransporter-2 Inhibition Benefits in Cardiorenal Risk in Men and Women.
Pruett JE, Lirette ST, Romero DG, Yanes Cardozo LL.
Pruett JE, et al.
J Endocr Soc. 2022 Dec 13;7(2):bvac191. doi: 10.1210/jendso/bvac191. eCollection 2022 Dec 15.
J Endocr Soc. 2022.
PMID: 36601021
Free PMC article.
Review.
Item in Clipboard
Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
Pruett JE, Torres Fernandez ED, Everman SJ, Vinson RM, Davenport K, Logan MK, Ye SA, Romero DG, Yanes Cardozo LL.
Pruett JE, et al.
Int J Mol Sci. 2021 Mar 4;22(5):2576. doi: 10.3390/ijms22052576.
Int J Mol Sci. 2021.
PMID: 33806551
Free PMC article.
Item in Clipboard
Cite
Cite